Provider P80-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 4, 2021 Read More
Provider P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers Read More
Provider P79-20 Change in Medical Necessity Criteria to InterQual® for Substance Use Disorder Admissions Read More
Provider P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers Read More
Provider P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers Read More
Provider QP50-19 Pharmacy Benefit Exclusion for Intramuscular Route of Administration Medications Read More
Provider QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services Read More
Provider QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg Read More
Provider QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services Read More
